Research
ZUPREVO® has been evaluated in several trials and studies.
Zuprevo-Speed-of-Action-TSB
ZUPREVO Proven speed of action in dairy calf ranches in California, feedyards in Nebraska and starter yards in Alabama
Zuprevo-HistophilusSomni
Histophilosis: The compelling case for using ZUPREVO in treatment of BRD caused by Histophilus somni
Zuprevo-Canada-TSB
Canadian commercial feedlot study comparing ZUPREVO to Draxxin® and Micotil® when used on arrival in calves at high risk of developing BRD
Zuprevo-10-Day-Challenge-Study-TSB
Determination of the amount of pulmonary lesions when cattle are challenged with Mannheimia haemolytica 10 days after administration of either tildipirosin (ZUPREVO) or tulathromycin (Draxxin®)
Zuprevo-tildipirosin-Antibiotic-BRD-Risk-Factor-Check-List
ZUPREVO (tildipirosin) Antibiotic BRD Risk Factor Check List
Comparison-of-Zuprevo-tildipirosin-and-Draxxin-tulathromycin-in-the-Control-of-BRD-in-Calf-Ranch-Cattle
Comparison of ZUPREVO (tildipirosin) and Draxxin (tulathromycin) in the Control of BRD in Calf Ranch Cattle
Technical-Bulletin-5-day-Histophillus-Challenge
Technical Bulletin: 5 day Histophilus Challenge
Technical-Bulletin-Zuprevo-vs.-Nuflor-Draxxin-and-Bio-Mycin-2016
Technical Bulletin: ZUPREVO vs. Nuflor, Draxxin and Bio-Mycin_2016
No items to show.
Residue Warning
Cattle intended for human consumption must not be slaughtered within 21 days of the last treatment. Do not use in female dairy cattle 20 months of age or older. Use of this drug product in these cattle may cause milk residues. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.
Important Safety Information
Zuprevo: FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. TO AVOID ACCIDENTAL INJECTION, DO NOT USE IN AUTOMATICALLY POWERED SYRINGES WHICH HAVE NO ADDITIONAL PROTECTION SYSTEM. IN CASE OF HUMAN INJECTION, SEEK MEDICAL ADVICE IMMEDIATELY AND SHOW THE PACKAGE INSERT OR LABEL TO THE PHYSICIAN. Cattle intended for human consumption must not be slaughtered within 21 days of the last treatment. Do not use in female dairy cattle 20 months of age or older. Use of this drug product in these cattle may cause milk residues. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. The effects of Zuprevo®18% on bovine reproductive performance, pregnancy and lactation have not been determined. Swelling and inflammation, which may be severe, may be seen at the injection site after administration. Subcutaneous injection may result in local tissue reactions which persist beyond slaughter withdrawal period. This may result in trim loss of edible tissue at slaughter.
DO NOT USE Zuprevo®18% IN SWINE. Fatal adverse events have been reported following the use of tildipirosin in swine. NOT FOR USE IN CHICKENS OR TURKEYS.
Get the latest updates! Sign up to receive cattle health management insights, industry news and more sent straight to your inbox.